ARROWHEAD PHARMACEUTICALS, INC. (ARWR) Operating cash flow 2016–2025
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$179.6MFY2025 · since FY2016: -$64.4M → $179.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $179.6M | +138.8% |
| FY2024 | -$462.9M | -200.8% |
| FY2023 | -$153.9M | -13.0% |
| FY2022 | -$136.1M | -179.5% |
| FY2021 | $171.3M | +278.8% |
| FY2020 | -$95.8M | -155.4% |
| FY2019 | $173.0M | +466.4% |
| FY2018 | -$47.2M | -97.3% |
| FY2017 | -$23.9M | +62.8% |
| FY2016 | -$64.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice